Cargando…

Free ubiquitin: a novel therapeutic target for neurodegenerative diseases

Detalles Bibliográficos
Autores principales:	Park, Chul-Woo, Ryu, Kwon-Yul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8328775/ https://www.ncbi.nlm.nih.gov/pubmed/33510075 http://dx.doi.org/10.4103/1673-5374.306075

Ejemplares similares

Ubiquitin homeostasis: from neural stem cell differentiation to neuronal development
por: Ryu, Han-Wook, et al.
Publicado: (2015)

Lipocalin-2: a therapeutic target to overcome neurodegenerative diseases by regulating reactive astrogliosis
por: Jung, Byung-Kwon, et al.
Publicado: (2023)

Reduced free ubiquitin levels and proteasome activity in cultured neurons and brain tissues treated with amyloid beta aggregates
por: Park, Chul-Woo, et al.
Publicado: (2020)

Cellular ubiquitin pool dynamics and homeostasis
por: Park, Chul-Woo, et al.
Publicado: (2014)

Therapeutic potential of lysosomal cathepsins for neurodegenerative diseases
por: Prieto Huarcaya, Susy, et al.
Publicado: (2022)

Microglia-targeting nanotherapeutics for neurodegenerative diseases
por: Zhao, Nanxia, et al.
Publicado: (2020)

Therapeutic potential of trehalose in neurodegenerative diseases: the knowns and unknowns
por: Khalifeh, Masoomeh, et al.
Publicado: (2021)

Therapeutic induction of autophagy to modulate neurodegenerative disease progression
por: Hochfeld, Warren E, et al.
Publicado: (2013)

Targeting mechanisms in cognitive training for neurodegenerative diseases
por: Venneri, Annalena, et al.
Publicado: (2020)

Current and future therapeutic strategies for the treatment of retinal neurodegenerative diseases
por: Maneu, Victoria, et al.
Publicado: (2021)

Role of the NLRP3 inflammasome in neurodegenerative diseases and therapeutic implications
por: Duan, Yanhui, et al.
Publicado: (2020)

Targeting glial metabolism in neurodegenerative diseases: detail matters
por: Afridi, Ruqayya, et al.
Publicado: (2023)

Shifting balance from neurodegeneration to regeneration of the brain: a novel therapeutic approach to Alzheimer's disease and related neurodegenerative conditions
por: Iqbal, Khalid, et al.
Publicado: (2014)

Abscisic acid, a promising therapeutic molecule to prevent Alzheimer’s and neurodegenerative diseases
por: Sánchez-Pérez, Ana María
Publicado: (2019)

Targeting Ubiquitin-Proteasome Pathway by Natural Products: Novel Therapeutic Strategy for Treatment of Neurodegenerative Diseases
por: Momtaz, Saeideh, et al.
Publicado: (2020)

Targeting the epigenome to treat neurodegenerative diseases or delay their onset: a perspective
por: Coppedè, Fabio
Publicado: (2022)

Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets
por: Kwon, Somin, et al.
Publicado: (2020)

ATP-binding cassette transporters as possible targets for the intervention of neurodegenerative diseases
por: Lok, Hiu Chuen, et al.
Publicado: (2023)

Non-Clinical Models for Neurodegenerative Diseases: Therapeutic Approach and Drug Validation in Animal Models
por: Fernandez, Caridad Ivette, et al.
Publicado: (2017)

Abnormal metal homeostasis as a common drug target to combat neurodegenerative diseases
por: Pretsch, Dagmar
Publicado: (2021)

Nuclear sphingomyelin in neurodegenerative diseases
por: Albi, Elisabetta, et al.
Publicado: (2021)

Potential therapeutic interventions based on the role of the endoplasmic reticulum stress response in progressive neurodegenerative diseases
por: Puri, Basant K., et al.
Publicado: (2018)

Immune inflammatory modulation as a potential therapeutic strategy of stem cell therapy for ALS and neurodegenerative diseases
por: Kim, Seung Hyun, et al.
Publicado: (2018)

Significance of intercellular communication for neurodegenerative diseases
por: Cihankaya, Hilal, et al.
Publicado: (2021)

Tayloring cell populations for neurodegenerative diseases
por: Fortin, Jeff M., et al.
Publicado: (2016)

Overcoming mitochondrial dysfunction in neurodegenerative diseases
por: Pessoa, João, et al.
Publicado: (2022)

Metabolic checkpoints in neurodegenerative T helper 17 (T(H)17) and neuroregenerative regulatory T (T(reg)) cells as new therapeutic targets for multiple sclerosis
por: Shen, Hongxing, et al.
Publicado: (2019)

Microparticles as Novel Biomarkers and Therapeutic Targets in Coronary Heart Disease
por: Zhou, Bo-Da, et al.
Publicado: (2015)

Regulation of polyubiquitin genes to meet cellular ubiquitin requirement
por: Han, Seung-Woo, et al.
Publicado: (2021)

Insights into the protective role of immunity in neurodegenerative disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

Protection against neurodegenerative disease on Earth and in space
por: Takamatsu, Yoshiki, et al.
Publicado: (2016)

Impact of the metabolic syndrome on the evolution of neurodegenerative diseases
por: de A. Boleti, Ana Paula, et al.
Publicado: (2020)

Polyglutamine diseases: looking beyond the neurodegenerative universe
por: Mielcarek, Michal, et al.
Publicado: (2020)

Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
por: Jiang, Ziying, et al.
Publicado: (2022)

Enterovirus infection and its relationship with neurodegenerative diseases
por: Sousa, Ivanildo Pedro, et al.
Publicado: (2023)

Ubiquitin pathways in neurodegenerative disease
por: Atkin, Graham, et al.
Publicado: (2014)

Ubiquitin, Autophagy and Neurodegenerative Diseases
por: Watanabe, Yoshihisa, et al.
Publicado: (2020)

Tubulin glutamylation: a skeleton key for neurodegenerative diseases
por: van der Laan, Siem, et al.
Publicado: (2019)

PERK: a novel therapeutic target for neurodegenerative diseases?
por: Ma, Tao, et al.
Publicado: (2014)

Disease-associated oligodendrocyte signatures in neurodegenerative disease: the known and unknown
por: Schuster, Kristen H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4uhlnja3lj6eoka7i6686scnka